Physician profile
Phyllis D Oster
NPI 1902817919
$1,642.86
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $1,049 · 2021: $172.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $254.29 | 2019-2020 | |
| Abbvie INC. | $224.18 | 2020 | |
| Janssen Biotech, INC. | $155.86 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $122.92 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $111.55 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.13 | 2019-2020 | |
| Pfizer INC. | $87.89 | 2020 | |
| Glaxosmithkline, LLC. | $87.09 | 2020-2021 | |
| Pulmonx Corporation | $74.57 | 2020 | |
| Allergan, INC. | $74.44 | 2019-2020 | |
| Covidien Lp | $53.34 | 2019-2020 | |
| Novo Nordisk INC | $43.47 | 2020 | |
| Lilly USA, LLC | $40.23 | 2019-2020 | |
| Genzyme Corporation | $37.38 | 2019-2020 | |
| Ethicon US, LLC | $33.75 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $25.07 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.64 | 2020 | |
| Boston Scientific Corporation | $21.68 | 2019 | |
| Amag Pharmaceuticals, INC. | $20.32 | 2019 | |
| Exeltis, USA INC. | $19.66 | 2020 | |
| Si-Bone, INC. | $15.63 | 2019 | |
| Sanofi Pasteur INC. | $15.43 | 2019 | |
| Evofem Biosciences, INC. | $11.34 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phyllis Oster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.